-
Bromocriptine, a dopamine receptor agonist initially approved in 1978 as Parlodel®, has been approved for the treating type 2 diabetes mellitus. The drug is marketed as a quick release formulation by VeroScience LLC as Cycloset™.
-
Group visits of diabetic patients have the power to foster lifestyle change, improve the control of diabetes and related cardiovascular risk factors, and lower health care costs.
-
Aspirin reduces the risk for myocardial infarction in men ages 45-79 and for stroke in women ages 55-79; however, its use must be balanced against the increased risk of serious bleeding events in each individual patient.
-
The combination of aspirin with clopidogrel is better than aspirin alone in reducing the risk of stroke in patients with atrial fibrillation.
-
In this rare 40-year follow-up study of children with epilepsy, those with idiopathic seizures were more easily controlled and more likely to enter remission compared to those with symptomatic seizures who are at greater risk for seizure refractoriness and mortality.
-
Antihypertensive treatment may reduce the risk of dementia as well as Alzheimer's-type pathology.
-
The risk of peripheral neuropathy gradually increases with a rise in fasting blood sugar, even at levels below that traditionally defined as diabetes mellitus.
-
-
Cavernous malformations are found in the brain and spinal cord of children but the correlation between the symptoms at diagnosis and the lesion should be considered prior to referral for surgical resection.
-
Although rare, spinal cord infarction should be considered in any patient with acute back or neck pain associated with paraparesis.